Recombinant multi-species FCRL5/CD307e protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FCRL5/CD307e protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the immunoglobulin receptor superfamily and the Fc-receptor like family. This gene and several other Fc receptor-like gene members are clustered on the long arm of chromosome 1. The encoded protein is a single-pass type I membrane protein and contains 8 immunoglobulin-like C2-type domains. This gene is implicated in B cell development and lymphomagenesis. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2010]
The Alternative Names of target: BXMAS1,CD307,CD307e,FCRH5,FCRL5,Fc receptor homolog 5 (FcRH5),Fc receptor-like protein 5,FcR-like protein 5,FcRL5,Fcrl3,Fcrl5,IRTA2,Immune receptor translocation-associated protein 2,PRO820

Target products collectionGo to FCRL5/CD307e products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0212-Ag-1/ GM-Tg-hg-SE0212-Ag-2 Human FCRL5/CD307e protein Human
GM-Tg-rg-SE0212-Ag-1/ GM-Tg-rg-SE0212-Ag-2 Rat FCRL5/CD307e protein Rat
GM-Tg-mg-SE0212-Ag-1/ GM-Tg-mg-SE0212-Ag-2 Mouse FCRL5/CD307e protein Mouse
GM-Tg-cynog-SE0212-Ag-1/ GM-Tg-cynog-SE0212-Ag-2 Cynomolgus/Rhesus macaque FCRL5/CD307e protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0212-Ag-1/ GM-Tg-felg-SE0212-Ag-2 Feline FCRL5/CD307e protein Feline
GM-Tg-cang-SE0212-Ag-1/ GM-Tg-cang-SE0212-Ag-2 Canine FCRL5/CD307e protein Canine
GM-Tg-bovg-SE0212-Ag-1/ GM-Tg-bovg-SE0212-Ag-2 Bovine FCRL5/CD307e protein Bovine
GM-Tg-equg-SE0212-Ag-1/ GM-Tg-equg-SE0212-Ag-2 Equine FCRL5/CD307e protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0212-Ag-1/ GM-Tg-hg-SE0212-Ag-2; GM-Tg-rg-SE0212-Ag-1/ GM-Tg-rg-SE0212-Ag-2;
GM-Tg-mg-SE0212-Ag-1/ GM-Tg-mg-SE0212-Ag-2; GM-Tg-cynog-SE0212-Ag-1/ GM-Tg-cynog-SE0212-Ag-2;
GM-Tg-felg-SE0212-Ag-1/ GM-Tg-felg-SE0212-Ag-2; GM-Tg-cang-SE0212-Ag-1/ GM-Tg-cang-SE0212-Ag-2;
GM-Tg-bovg-SE0212-Ag-1/ GM-Tg-bovg-SE0212-Ag-2; GM-Tg-equg-SE0212-Ag-1/ GM-Tg-equg-SE0212-Ag-2
Products Name FCRL5/CD307e protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FCRL5/CD307e
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FCRL5/CD307e protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.